Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Scienture Holdings (SCNX) Research & Development (2021 - 2025)

Scienture Holdings' Research & Development history spans 5 years, with the latest figure at $4477.0 for Q4 2025.

  • On a quarterly basis, Research & Development fell 99.77% to $4477.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $610320.0, a 72.71% decrease, with the full-year FY2025 number at $97261.0, down 95.65% from a year prior.
  • Research & Development hit $4477.0 in Q4 2025 for Scienture Holdings, down from $9756.0 in the prior quarter.
  • Over the last five years, Research & Development for SCNX hit a ceiling of $1.9 million in Q4 2024 and a floor of $4477.0 in Q4 2025.
  • Historically, Research & Development has averaged $247507.5 across 5 years, with a median of $141028.5 in 2021.
  • Biggest five-year swings in Research & Development: surged 7561.35% in 2024 and later plummeted 99.77% in 2025.
  • Tracing SCNX's Research & Development over 5 years: stood at $221595.0 in 2021, then soared by 36.42% to $302310.0 in 2022, then plummeted by 91.62% to $25334.0 in 2023, then surged by 7561.35% to $1.9 million in 2024, then plummeted by 99.77% to $4477.0 in 2025.
  • Business Quant data shows Research & Development for SCNX at $4477.0 in Q4 2025, $9756.0 in Q3 2025, and $21408.0 in Q2 2025.